Peripheral arterial tone: assessment of microcirculatory function in pregnancy

Objective Endothelial dysfunction is known to play a key role in the pathogenesis of preeclampsia, but the majority of methods for its detection are too invasive to be used in pregnancy. In this study we report a novel method – peripheral arterial tonometry (PAT) – for examining microcirculatory function in pregnancy. Methods One hundred and eighty women with at least two risk factors for preeclampsia were examined at gestational weeks 16 and 28; 80 women were examined at 6–9 months postnatally. Twenty-four women developed preeclampsia or pregnancy-induced hypertension (cases), 156 remained normotensive (controls). PAT was measured using fingertip pneumatic probes; after baseline recordings the study arm was occluded with a blood pressure cuff then released after 5 min, causing reactive hyperaemia. PAT recordings pre and post occlusion were used to generate the reactive hyperaemia index (RHI). Results RHI was significantly lower at gestational week 28 compared to week 16, both in cases and controls. Baseline pulse amplitude was significantly higher at week 28 compared to week 16. There was no difference in RHI at either week 16 or 28 between cases and controls. Postnatally, there was no difference in RHI between cases and controls, but baseline pulse amplitude was lower in affected women. Conclusion PAT and other methods which rely on flow-mediated dilatation for detection of endothelial dysfunction are less likely to be reliable in later pregnancy, when women are more vasodilated. PAT did not predict the development of hypertensive pregnancy complications, but demonstrated a relative peripheral vasoconstriction in affected women postnatally.

[1]  L. Poston,et al.  Urinary Proteomics for Prediction of Preeclampsia , 2011, Hypertension.

[2]  S. Daniels,et al.  Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. , 2009, Hypertension.

[3]  I. Sargent,et al.  Placental stress and pre-eclampsia: a revised view. , 2009, Placenta.

[4]  A. Hingorani,et al.  Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[5]  T. Laitinen,et al.  Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[6]  A. Hingorani,et al.  Preeclampsia and Risk of Cardiovascular Disease and Cancer in Later Life: Systematic Review and Meta-analysis , 2008 .

[7]  Ramachandran S Vasan,et al.  Cross-Sectional Relations of Digital Vascular Function to Cardiovascular Risk Factors in the Framingham Heart Study , 2008, Circulation.

[8]  K. Nicolaides,et al.  Maternal Wave Reflections and Arterial Stiffness in Normal Pregnancy as Assessed by Applanation Tonometry , 2008, Hypertension.

[9]  A. Hamsten,et al.  Decreased flow-mediated dilation is present 1 year after a pre-eclamptic pregnancy , 2007, Journal of hypertension.

[10]  A. Hingorani,et al.  Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[11]  R. Karas,et al.  Assessment of peripheral vascular endothelial function in the ambulatory setting , 2007, Vascular medicine.

[12]  A. Quinton,et al.  A Longitudinal Study Using Ultrasound to Assess Flow-Mediated Dilatation in Normal Human Pregnancy , 2007, Hypertension in pregnancy.

[13]  A. Malhotra,et al.  Pre-eclampsia is associated with sleep-disordered breathing and endothelial dysfunction , 2006, European Respiratory Journal.

[14]  Kirsten Duckitt,et al.  Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies , 2005, BMJ : British Medical Journal.

[15]  Amir Lerman,et al.  Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. , 2004, Journal of the American College of Cardiology.

[16]  W. Walters,et al.  Endothelial cell function enhancement in a late normal human pregnancy , 2004, The Australian & New Zealand journal of obstetrics & gynaecology.

[17]  C. Ananth,et al.  Noninvasive Ultrasound Assessment of Maternal Vascular Reactivity During Pregnancy: A Longitudinal Study , 2004, Obstetrics and gynecology.

[18]  Lewis H Kuller,et al.  Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. , 2004, American journal of physiology. Heart and circulatory physiology.

[19]  J. Kooner,et al.  Association of maternal endothelial dysfunction with preeclampsia. , 2001, JAMA.

[20]  Jean-Marie Moutquin,et al.  The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) , 2001, Hypertension in pregnancy.

[21]  S. Nakao,et al.  Flow-Mediated Vasodilation and Plasma Fibronectin Levels in Preeclampsia , 2000, Hypertension.

[22]  K. Sørensen,et al.  Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation. , 1999, American journal of physiology. Heart and circulatory physiology.

[23]  L. Poston,et al.  Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. , 1997, Hypertension.

[24]  J. K. Lloyd,et al.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.

[25]  P. López-Jaramillo,et al.  Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. , 2007, American journal of hypertension.